share_log

bluebird bio | SC 13G: Statement of acquisition of beneficial ownership by individuals-THE GOLDMAN SACHS GROUP, INC.(6.4 %),GOLDMAN SACHS & CO. LLC(6.4 %)

SEC announcement ·  Feb 7 05:53
Summary by Futu AI
On December 29, 2023, a Schedule 13G filing was made with the United States Securities and Exchange Commission (SEC) by The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC, indicating a significant investment in bluebird bio, Inc. The filing revealed that Goldman Sachs collectively owns 12,181,040 shares of bluebird bio, which represents approximately 0.4% of the company's common stock. The shares are held with shared voting and dispositive power. The filing was made under Rule 13d-1(b), which is typically used by passive investors to report holdings. The address for both The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC is 200 West Street, New York, NY. The filing included a certification that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer, nor in connection with any transaction having such purpose or effect.
On December 29, 2023, a Schedule 13G filing was made with the United States Securities and Exchange Commission (SEC) by The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC, indicating a significant investment in bluebird bio, Inc. The filing revealed that Goldman Sachs collectively owns 12,181,040 shares of bluebird bio, which represents approximately 0.4% of the company's common stock. The shares are held with shared voting and dispositive power. The filing was made under Rule 13d-1(b), which is typically used by passive investors to report holdings. The address for both The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC is 200 West Street, New York, NY. The filing included a certification that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer, nor in connection with any transaction having such purpose or effect.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.